Evidence map›Paper›PMID 42550460›Full record

ArticleLa Radiologia medica2026

Radiological review of interval breast cancers following screening with DBT + DM or DM: results from MAITA project randomized trials.

Valentina Iotti, Alfonso Frigerio, Pamela Mancuso, Daniela Ambrogetti, Fabio Falcini, Vladimiro Ginocchi, Axel Graewingholt, Kristina Lang, Vincenzo Marra, Manuela Pescarolo and 17 more

Abstract read
PubMed Publisher
In one paragraph

Article in La Radiologia medica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Valentina Iotti *AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Alfonso Frigerio *Senologia di Screening AOU Città della Salute e della Scienza, CPO Piemonte, Turin, Italy.
Pamela MancusoAUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy. pamela.mancuso@ausl.re.it.ORCID http://orcid.org/0000-0003-1609-2440
Daniela AmbrogettiISPRO - Istituto per lo Studio, la Prevenzione e la Rete Oncologica, Florence, Italy.
Fabio FalciniRomagna Cancer Institute, IRCCS Istituto Romagnolo per lo Studio dei Tumori IRST "Dino Amadori", Meldola, Forlì, Italy.
Vladimiro GinocchiAUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Axel GraewingholtMammographiescreening-Zentrum Paderborn, Breast Cancer Screening, Paderborn, NRW, Germany.
Kristina LangDepartement of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden.
Vincenzo MarraSenologia di Screening AOU Città della Salute e della Scienza, CPO Piemonte, Turin, Italy.
Manuela PescaroloAUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Giovanna RomanucciBreast Unit ULSS9 Scaligera, Ospedale Fracastoro, San Bonifacio, Verona, Italy.
Claudia RossatiBreast Unit ULSS9 Scaligera, Ospedale Fracastoro, San Bonifacio, Verona, Italy.
Gabriele RossiniScuola di Specializzazione in Radio Diagnostica, Università Degli Studi di Milano, Milan, Italy.
Francesco SardanelliLega Italiana per la Lotta contro i Tumori LILT Milano Monza Brianza, Milan, Italy.
Rita VacondioAUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Cinzia CampariAUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Patrizia FaliniISPRO - Istituto per lo Studio, la Prevenzione e la Rete Oncologica, Florence, Italy.
Francesca FornasaBreast Unit ULSS9 Scaligera, Ospedale Fracastoro, San Bonifacio, Verona, Italy.
Paola MantelliniISPRO - Istituto per lo Studio, la Prevenzione e la Rete Oncologica, Florence, Italy.ORCID http://orcid.org/0000-0003-4114-4011
Stefania MontemezziRadiology Unit, University Hospital of Verona, Verona, Italy.
Andrea NitrosiAUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Pierpaolo PattaciniAUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Francesca PeruzziISPRO - Istituto per lo Studio, la Prevenzione e la Rete Oncologica, Florence, Italy.
Antonio PontiSSD Epidemiologia e Screening, AOU Città della Salute e della Scienza, CPO Piemonte, Turin, Italy.
Paola Armaroli *SSD Epidemiologia e Screening, AOU Città della Salute e della Scienza, CPO Piemonte, Turin, Italy.
Paolo Giorgi Rossi *AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.ORCID http://orcid.org/0000-0001-9703-2460
MAITA Working Group

Funding

Ministero della Salute RF- 2016-02363686
6 · The paper itself

Abstract

purposeCompare the radiological characteristics of screening images preceding interval cancers that occurred in women screened with digital breast tomosynthesis (DBT) plus digital mammography (DM) vs. those in women screened with DM alone. MATERIALS AND

methodsFrom two randomized trials comparing DBT + DM vs. DM, 91 (43 from DBT + DM arm and 48 from DM arm) images preceding interval cancers and 190 (94 and 96, respectively) negative controls were reviewed by three radiologists using only DM screening mammograms and by three different radiologists using all available images, i.e. DBT and DM for the experimental arm and DM for the standard arm. The cancers were classified according to the number of reviewers that found abnormalities, as true negative (negative for all three reviewers), minimal sign (positive for one and negative for two), and false negative (positive for two or three reviewers).

resultsIn the DM arm, interval cancers were classified as true negative in 29-42%, minimal signs in 31-35%, and false negative in 27-35%; in the DBT arm, the proportion of true negative was 40%, minimal signs 21%, and false negatives 40% when the review was performed using only DM images, 30%, 28%, and 42% when the reviewers read both DBT and DM screening images. The differences were compatible with random fluctuations.

conclusionThe radiological analysis of interval cancers after DBT + DM and after DM alone showed similar characteristics, confirming that the impact of DBT on interval cancer incidence is small both in terms of quantity and type.

Indexed as

Digital breast tomosynthesisDigital mammographyInterval breast cancersRadiological review

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.